Jan 3, 2011 21:13
13 yrs ago
1 viewer *
Spanish term
carbo monoagente
Spanish to English
Medical
Medical (general)
Lab tests
ANALISIS
Paciente con HC anotada, predomina el componente de alto grado del ca del ovario.
PLAN
SS
CH PLAQUETAS TGO TGP LDH F ALCALINA CREATININA, DEPURACION DE CREATININA EN ORINA DE 24 HORAS, ACE, CA 125, PREINICIO de quimio. Se verá con resultados para formular, posiblemente con CARBO MONOAGENTE PARA PROBAR TOLERANCIA.
From a Colombian hospital report on a patient with ovarian cancer.
Paciente con HC anotada, predomina el componente de alto grado del ca del ovario.
PLAN
SS
CH PLAQUETAS TGO TGP LDH F ALCALINA CREATININA, DEPURACION DE CREATININA EN ORINA DE 24 HORAS, ACE, CA 125, PREINICIO de quimio. Se verá con resultados para formular, posiblemente con CARBO MONOAGENTE PARA PROBAR TOLERANCIA.
From a Colombian hospital report on a patient with ovarian cancer.
Proposed translations
(English)
4 +3 | carboplatin monotherapy | Filippe Vasconcellos de Freitas Guimarães |
4 +4 | Single-agent carbo(platin) | lorenab23 |
Proposed translations
+3
6 mins
Selected
carboplatin monotherapy
"carbo" is probably "carboplatina", a chemotherapeutic agent.
--------------------------------------------------
Note added at 9 mins (2011-01-03 21:22:56 GMT)
--------------------------------------------------
Carboplatin is used to treat ovarian, lung, and other cancers.
http://www.cancer.org/Treatment/TreatmentsandSideEffects/Gui...
--------------------------------------------------
Note added at 9 mins (2011-01-03 21:22:56 GMT)
--------------------------------------------------
Carboplatin is used to treat ovarian, lung, and other cancers.
http://www.cancer.org/Treatment/TreatmentsandSideEffects/Gui...
Note from asker:
Yes, I found carboplatin monotherapy later in the document. Thanks. |
4 KudoZ points awarded for this answer.
Comment: "Thanks"
+4
15 mins
Single-agent carbo(platin)
Single-agent carboplatin is acceptable as first-line chemotherapy for ovarian cancer, with its superior toxicity profile and equivalent survival benefit compared with other regimens, according to the results of a randomized trial reported in the August 17, 2002 issue of The Lancet.
http://csn.cancer.org/node/196114
The report of the International Collaborative Ovarian Neoplasm (ICON) Group (August 17, p 505)1 concluded that single-agent carbo-platin is a reasonable option as first-line chemotherapy for ovarian cancer. Despite these results, we believe that carboplatin plus paclitaxel remains the standard of care for previously untreated patients with advanced ovarian cancer
http://www.thelancet.com/journals/lancet/article/PIIS0140-67...
1.In this small series with a median follow-up of>2 years single-
agent carbo has so far achieved a relapse rate of 5%.
http://www.bococ.org.cy/ESMO 2008.pdf
http://csn.cancer.org/node/196114
The report of the International Collaborative Ovarian Neoplasm (ICON) Group (August 17, p 505)1 concluded that single-agent carbo-platin is a reasonable option as first-line chemotherapy for ovarian cancer. Despite these results, we believe that carboplatin plus paclitaxel remains the standard of care for previously untreated patients with advanced ovarian cancer
http://www.thelancet.com/journals/lancet/article/PIIS0140-67...
1.In this small series with a median follow-up of>2 years single-
agent carbo has so far achieved a relapse rate of 5%.
http://www.bococ.org.cy/ESMO 2008.pdf
Peer comment(s):
agree |
Filippe Vasconcellos de Freitas Guimarães
: Also a great choice.
15 mins
|
agree |
Otto Albers (X)
24 mins
|
agree |
Muriel Vasconcellos
51 mins
|
agree |
Wendy Cummings
17 hrs
|
Something went wrong...